- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07792525
Conventional Versus 3D Printed Twin Block Appliances in Growth Modification of Class II Malocclusion (RCT)
August 27, 2026 updated by: Shimaa Hussein Rafat Kotb, Al-Azhar University
Conventional Versus 3D Printed Twin Block Appliances in Growth Modification of Class II Malocclusion (Comparative Clinical Study) A Thesis
The present study was conducted to evaluate the outcomes of conventionl versus 3D printed twin block appliances in growth modification of class II malocclusion (comparative clinical study) in both groups.
Study Overview
Detailed Description
The aim of this study was to evaluate the effects of treatment by conventional and 3D printed Twin Block for growth modification of class II malocclusion.
This study was carried out upon twenty young growing age patients with class II malocclusion retruded mandible.
The patients were selected from patients seeking orthodontic treatment in out-patient clinic, orthodontic department, Al-Azhar University, Asyut, Egypt.
They were randomly divided into two groups: each consisted of 10 patients as follows: The first group consisted of 10 patients, who received conventional twin block removable functional appliance therapy; the second group consisted of 10 patients, who received 3D printed twin block removable functional appliance therapy.
Study Type
Observational
Enrollment (Actual)
20
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Asyut, Egypt, 0000
- Al-Azhar University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Yes
Sampling Method
Probability Sample
Study Population
prospective, blind, clinical, and radiographic trial
Description
Inclusion Criteria:
- Young, growing age range from 9 to 16 years old.
- Class II malocclusion with retruded mandible.
- Increased overjet.
- Horizontal to average growth pattern determined by cephalometric radiograph.
- Positive pretreatment VTO detected by clinical examination. .
Exclusion Criteria:
- Severe proclination of anterior teeth.
- Severe crowding of anterior teeth.
- Systemic disease that affects bone and general growth
- History of previous orthodontic treatment.
- Patient refuses a removable appliance.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Group 1
conventional group
|
Removable orthodontic appliance for growth modification
|
|
Group 2
3D printed group
|
Removable orthodontic appliance for growth modification
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
cephalometric analysis of angular measurements pretreatment (T0),and post-treatment (T1)dental and skeletal changes
Time Frame: Baseline and 6 months after treatment
|
Mean values- Mean difference- p value
|
Baseline and 6 months after treatment
|
|
cephalometric analysis of Linear measurements pretreatment (T0),and post-treatment (T1) dental and skeletal changes
Time Frame: Baseline and 6 months after treatment
|
Mean values- Mean differences- P value
|
Baseline and 6 months after treatment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2024
Primary Completion (Actual)
March 1, 2026
Study Completion (Actual)
April 1, 2026
Study Registration Dates
First Submitted
August 13, 2026
First Submitted That Met QC Criteria
August 25, 2026
First Posted (Actual)
August 28, 2026
Study Record Updates
Last Update Posted (Actual)
August 31, 2026
Last Update Submitted That Met QC Criteria
August 27, 2026
Last Verified
August 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AUAREC20240003-7
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.